At Houston Methodist, our commitment is to make innovations that arise from our interdisciplinary clinical research teams accessible to patients, quickly and safely. Our mission is to innovate in health care technology and train current and future health care clinicians and researchers from around the world in the science and art of translational medicine. We support a global research collaboration network of teams with expertise in nontraditional platform technologies and programs, providing the administrative support, staff and facilities that are needed to rapidly translate discoveries into new diagnostics, therapies and treatments.
WEARABLE TMS DEVICE HELPS CONTROL DEPRESSION
Researchers at Houston Methodist and Weill Cornell have developed a portable, wearable system for transcranial magnetic stimulation to treat major depression. The device, a helmet cap with a handheld controller, can be used at home with a prescribed treatment protocol. Learn more.
COAPT TRIAL FOR LEAKY HEART VALVE
This trial will evaluate the safety and effectiveness of the MitraClip device for the treatment of moderate-to-severe or severe mitral valve leak, also called functional mitral regurgitation, in patients with heart failure. Learn more.
Meet Joseph Masdeu, MD, PhD
Dr. Joseph Masdeu, MD, PhD, the Graham Family Distinguished Chair for Neurological Sciences is on a mission to understand the neurobiology of Alzheimer’s disease and other neurodegenerative disorders though approaches like neuroimaging.
Magnetic nanoparticles could stop blood clot-caused strokeS
By loading magnetic nanoparticles with drugs and then biochemically camouflaging them, we can offer a technique that destroys blood clots 100 to 1,000 times faster than a traditional method. Learn more.